Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,775,463
-
Share change
-
-1,216,547
-
Total reported value
-
$1,302,258
-
Price per share
-
$0.4695
-
Number of holders
-
23
-
Value change
-
-$775,371
-
Number of buys
-
8
-
Number of sells
-
20
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q4 2016
As of 31 Dec 2016 TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,775,463 shares of stock of the company.
Largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BLUESTEIN R H & CO, FNY Managed Accounts LLC, OPPENHEIMER & CO INC, and BlackRock Fund Advisors.
This table shows 23 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.